SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited, the leader in modelling and simulation of drug-drug interactions in virtual human populations, today announces it has extended its animal models to include a virtual mouse.
Laboratory mice are used extensively in the development of new anti-cancer drugs as well as toxicological studies involving agrochemicals. This research often involves using mice which have been genetically modified in order to investigate the role that drug metabolising enzymes and transporters play in the accumulation of drugs in the whole animal or in specific tissues. The Simcyp Mouse provides a virtual environment for evaluating drug disposition which will replace the need for some live animal testing in normal as well as transgenic mice, thus reducing and refining preclinical investigation.
Laboratory mice are used extensively in the development of new anti-cancer drugs as well as toxicological studies involving agrochemicals. This research often involves using mice which have been genetically modified in order to investigate the role that drug metabolising enzymes and transporters play in the accumulation of drugs in the whole animal or in specific tissues. The Simcyp Mouse provides a virtual environment for evaluating drug disposition which will replace the need for some live animal testing in normal as well as transgenic mice, thus reducing and refining preclinical investigation.
